FDA rejects Vernalis’ cough cold treatment

21st April 2017 Uncategorised 0

The US Food and Drug Administration has rejected Vernalis’ cough cold treatment CCP-07, which is being developed by US partner Tris Pharma.

More: FDA rejects Vernalis’ cough cold treatment
Source: News